Tag: Optimi Health - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial

Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial

Post published:September 14, 2023
Post category:Press Release

Read more about the article Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program

Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program

Post published:September 7, 2023
Post category:Press Release

Read more about the article Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing

Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing

Post published:September 5, 2023
Post category:Press Release

Read more about the article Optimi Health Announces CAD $3,000,000 Senior Debt Financing

Optimi Health Announces CAD $3,000,000 Senior Debt Financing

Post published:August 10, 2023
Post category:Press Release

Read more about the article Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

Post published:August 1, 2023
Post category:Press Release

Read more about the article Optimi Health Announces Receipt of Purported Termination Notice

Optimi Health Announces Receipt of Purported Termination Notice

Post published:July 27, 2023
Post category:Press Release

Read more about the article Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS

Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS

Post published:June 15, 2023
Post category:Press Release

Read more about the article Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market

Optimi Health Completes Harvest Of Psilocybe Cubensis For Delivery To The Australian Medical Market

Post published:May 17, 2023
Post category:Press Release

Read more about the article Optimi Health Granted Natural Health Product Site Licence By Health Canada

Optimi Health Granted Natural Health Product Site Licence By Health Canada

Post published:May 10, 2023
Post category:Press Release

Read more about the article Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and Development

Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical Research and Development

Post published:May 4, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.